VMP 38893911000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Fesoterodine 8mg modified-release tablets
BNF code 0704020ADAAABAB
Virtual Therapeutic Moiety Fesoterodine
Date identifier became valid 19 Aug 2020
Previous product identifier 442489000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Fesoterodine fumarate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 8.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tabletmodified-release.oral
Dose Form
Formulation Modified-release tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Fesoterodine 8mg modified-release tablets (A A H Pharmaceuticals Ltd)
Fesoterodine 8mg modified-release tablets (Accord-UK Ltd)
Fesoterodine 8mg modified-release tablets (Aristo Pharma Ltd)
Fesoterodine 8mg modified-release tablets (Aspire Pharma Ltd)
Fesoterodine 8mg modified-release tablets (Celix Pharma Ltd)
Fesoterodine 8mg modified-release tablets (Dr Reddy's Laboratories (UK) Ltd)
Fesoterodine 8mg modified-release tablets (Genus Pharmaceuticals Ltd)
Fesoterodine 8mg modified-release tablets (Medical Valley Invest AB)
Fesoterodine 8mg modified-release tablets (Zentiva Pharma UK Ltd)
Teraleve 8mg modified-release tablets (Dr Reddy's Laboratories (UK) Ltd)
Toviaz 8mg modified-release tablets (Pfizer Ltd)
Virtual Medicinal Product Packs
Fesoterodine 8mg modified-release tablets 28 tablet
Fesoterodine 8mg modified-release tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback